Fairvalue-Calculator Fairvalue-Calculator
EN DE

HST Global, Inc (HSTC) Fair Value & Analysis

Healthcare · US · Market cap $99.0M

Price$0.7000
Fair Value$0.3900
Upside-44.3%
Quality95/100
Evidence: Low Range $0.2900 – $0.4900

Fair value as of: Jun 24, 2026

Analysis

HST Global, Inc (HSTC) currently trades at $0.7000, while our model-based Fair Value estimate is $0.3900 — implying the stock looks roughly 44.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

HST Global, Inc. operates in the healthcare, software and media, and transportation industries. It offers Qwyit, a cryptographic protocol. HST Global, Inc. is based in Virginia Beach, Virginia.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is HST Global, Inc (HSTC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.3900 versus a price of $0.7000 — about −44% (overvalued). Model-based estimate, not financial advice.
What is the fair value of HSTC?
Our 21-model fair value for HST Global, Inc is $0.3900 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.7000.
What is the quality score of HSTC?
HST Global, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.